| # | Drug | Count |
|---|---|---|
| 0 | FOLIC ACID | 41 |
| 1 | LEVETIRACETAM | 30 |
| 2 | ATAZANAVIR | 29 |
| 3 | RITONAVIR | 29 |
| 4 | LEVETIRACETAM IN SODIUM CHLORIDE | 27 |
| 5 | LEVETIRACETAM INJECTION | 27 |
| 6 | LEVETIRACETAM ORAL | 27 |
| 7 | RITONAVIR 100 MG | 23 |
| 8 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 19 |
| 9 | LAMOTRIGINE | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RALTEGRAVIR | 13 | 0.0025 |
| 1 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 1 | 0.0023 |
| 2 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| 3 | ATAZANAVIR | 29 | 0.0020 |
| 4 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 18 | 0.0020 |
| 5 | NEVIRAPINE | 15 | 0.0017 |
| 6 | RITONAVIR 100 MG | 23 | 0.0015 |
| 7 | NELFINAVIR MESYLATE | 3 | 0.0014 |
| 8 | METHYLDOPA | 7 | 0.0014 |
| 9 | MENOTROPINS | 2 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 32 | 0.0007 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 15 | 0.0006 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 33 | 0.0005 |
| 3 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 42 | 0.0004 |
| 5 | Anthelmintic [EPC] | 1 | 0.0003 |
| 6 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 7 | Nitrofuran Antibacterial [EPC] | 5 | 0.0003 |
| 8 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 9 | Progestin Antagonist [EPC] | 1 | 0.0002 |